Gold Colloid: 5nm -100ml

Added to your cart

Gold Colloid: 5nm -100ml

Cart subtotal: £0.00

View cart (0) Checkout

#SKU EM.GC5/7

£186.00

Price excludes shipping costs.
To view our shipping costs click here.

Need to order this product in bulk?

Contact our team of experts to discuss your bulk requirements

Contact our expert team

Product Details

We offer a 5nm gold which is ideal for a number of applications including Lateral flow assays, TEM, SEM, Environmental detection and purification, data storage, drug delivery, biomarkers, SERS, photo-thermolysis, catalysis, chemical sensors and DNA detection.

100mL
EM.GC5/7

More information

Attributes

Description

  • Shipping Information
  • Ambient Shipping
  • Reference Texts
  • Yi, Se Won et al. “Multiply clustered gold-based nanoparticles complexed with exogenous pDNA achieve prolonged gene expression in stem cells.” Theranostics vol. 9,17 5009-5019. 9 Jul. 2019, doi:10.7150/thno.34487
  • Specification
  • OD1, Mean size = 4.5nm - 6.0nm, %CV = ≤15%
  • Recommended Use
  • Elctron Micrioscopy / biosensors
  • Preservatives
  • None
  • Buffer
  • Purified Water
  • Capping Agent
  • Citrate
  • Optical Density
  • OD1
  • Particle Size
  • 5nm

Technical Documents

Certificates Of Analysis (224.44KB)

Safety Data Sheet (87.46KB)

Product Information (290.74KB)

Data Sheets (97.04KB) Lot 21030174

Data Sheets (97.06KB) Lot 21030175

Data Sheets (97.03KB) Lot 21030142

Data Sheets (97.36KB) Lot 20110148

Data Sheets (97.31KB) Lot 20070103

Sorry, no results found.

Enter the full lot number and hit enter.

BBI Solutions Brands

diarect.png

The acquisition of DIARECT in June 2020 and their world leading recombinant autoimmune antigen capability immediately enhances BBI’s portfolio and position as a ‘complete’ immunoassay reagent supplier. This further enhances BBI’s position as the world’s largest diagnostics components company with a market leading antigen portfolio.

mbs.png

Maine Biotechnology Services brings 27 years of knowledge, experience, process development, and project management to our customers to ensure the best possible antibodies for any application. As antibody development goals in the biotechnology and pharmaceutical industry have evolved the acquisition of MBS will help BBI further meet and exceed our customers needs.

Newsletter

Signup for our newsletter to receive the latest BBI Solutions updates and special offers in your inbox